BCK Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

BCK Capital Management’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$900K	Hold
2024 Q1	$930K	Hold
2023 Q4	$933K	Buy